> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Info Collection on Generic Drug Correspondence
- URL: https://www.fdaweb.com/info-collection-on-generic-drug-correspondence/
- Published: 2019-11-08T12:00:00.000Z
- Updated: 2026-09-14T15:52:26.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5145458

*Federal Register* notice: FDA has submitted to OMB an information collection revision entitled for “Controlled Correspondence Related to Generic Drug Development OMB Control No. 0910-0797." The revision responds to goals negotiated under the generic drug user fee program, which commits the agency to responding to questions submitted as controlled correspondence. To view the notice, click [here](https://s3.amazonaws.com/public-inspection.federalregister.gov/2019-24562.pdf?ref=fdaweb.com).